Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: Tools and applications

International Journal of Molecular Sciences

Volumn 15, Issue 1, 2014, Pages 684-711

  Del Chierico, Federica ^a   Gnani, Daniela ^a   Vernocchi, Pamela ^a,b   Petrucca, Andrea ^a,c   Alisi, Anna ^a   Dallapiccola, Bruno ^a   Nobili, Valerio ^a   Lorenza, Putignani ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Data integration; Diet; Gut microbiota; Meta omic platforms; Metabolic syndrome; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Obesity; Pediatric patients; Systems biology

Indexed keywords

INTERLEUKIN 1BETA; OLIGONUCLEOTIDE; PROBIOTIC AGENT; RNA 16S; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR; XENOBIOTIC AGENT;

BIOREACTOR; DNA EXTRACTION; DNA MICROARRAY; ENVIRONMENTAL FACTOR; FATTY LIVER; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; INTESTINE FLORA; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; POLYMERASE CHAIN REACTION; PROTON NUCLEAR MAGNETIC RESONANCE; PYROSEQUENCING; REVIEW; RISK FACTOR; ANIMAL; GASTROINTESTINAL TRACT; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; METAGENOMICS; MICROBIOLOGY; MICROFLORA; PATHOLOGY; PEPTIDE MAPPING; PROTEOMICS;

ANIMALS; GASTROINTESTINAL TRACT; HUMANS; METABOLOMICS; METAGENOMICS; MICROBIOTA; NON-ALCOHOLIC FATTY LIVER DISEASE; PEPTIDE MAPPING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84891851661     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15010684     Document Type: Review

References (124)

1. Xiao, J.; Guo, R.; Fung, M.L.; Liong, E.C.; Tipoe, G.L. Therapeutic approaches to non-alcoholic fatty liver disease: Past achievements and future challenges. Hepatobiliary Pancreat. Dis. Int. 2013, 12, 125-135.
2. Milić, S.; Stimac, D. Nonalcoholic fatty liver disease/steatohepatitis: Epidemiology, pathogenesis, clinical presentation and treatment. Digest. Dis. 2012, 30, 158-162.
3. Alisi, A.; Feldstein, A.E.; Villani, A.; Raponi, M.; Nobili, V. Pediatric nonalcoholic fatty liver disease: A multidisciplinary approach. Nat. Rev. Gastroenterol. Hepatol. 2012, 9, 152-161.
4. Brunt, E.M. Nonalcoholic fatty liver disease: What the pathologist can tell the clinician. Digest. Dis. 2012, 30, 61-68.
5. Nobili, V.; Svegliati-Baroni, G.; Alisi, A.; Miele, L.; Valenti, L.; Vajro, P. A 360-degree overview of paediatric NAFLD: Recent insights. J. Hepatol. 2013, 58, 1218-1229.
6. Duan, X.Y.; Qiao, L.; Fan, J.G. Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma. Hepatobiliary Pancreat. Dis. Int. 2012, 11, 18-27.
7. Day, C.P. Genetic and environmental susceptibility to non-alcoholic fatty liver disease. Digest. Dis. 2010, 28, 255-260.
8. De Alwis, N.M.; Day, C.P. Non-alcoholic fatty liver disease: The mist gradually clears. J. Hepatol. 2008, 48, 104-112.
9. Tiniakos, D.G.; Vos, M.B.; Brunt, E.M. Nonalcoholic fatty liver disease: Pathology and pathogenesis. Annu. Rev. Pathol. 2010, 5, 145-171.
10. Tilg, H.; Moschen, A.R. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrin. Met. 2008, 19, 371-379.
11. Alisi, A.; Locatelli, M.; Nobili, V. Nonalcoholic fatty liver disease in children. Curr. Opin. Clin. Nutr. 2010, 13, 397-402.
12. Larrain, S.; Rinella, M.E. A myriad of pathways to NASH. Clin. Liver Dis. 2012, 16, 525-548.
13. Savary, S.; Trompier, D.; Andréoletti, P.; Le Borgne, F.; Demarquoy, J.; Lizard, G. Fatty acids-Induced lipotoxicity and inflammation. Curr. Drug Metab. 2012, 13, 1358-1370.
14. Sookoian, S.; Pirola, C.J. DNA methylation and hepatic insulin resistance and steatosis. Curr. Drug Metab. 2012, 15, 350-356.
15. Koek, G.H.; Liedorp, P.R.; Bast, A. The role of oxidative stress in non-alcoholic steatohepatitis. Clin. Chim. Acta 2011, 412, 1297-1305.
16. Cusi, K. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: Pathophysiology and clinical implications. Gastroenterology 2012, 142, 711-725.
17. Fujii, H.; Kawada, N. Inflammation and fibrogenesis in steatohepatitis. J. Gastroenterol. 2012, 47, 215-225.
18. Kelishadi, R.; Mirghaffari, N.; Poursafa, P.; Gidding, S.S. Lifestyle and environmental factors associated with inflammation, oxidative stress and insulin resistance in children. Atherosclerosis 2009, 203, 311-319.
19. Feldstein, A.E. Novel insights into the pathophysiology of nonalcoholic fatty liver disease. Semin. Liver Dis. 2010, 30, 391-401.
20. Nseir, W.; Shalata, A.; Marmor, A.; Assy, N. Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease. Digest. Dis. Sci. 2011, 56, 3439-3449.
21. Wree, A.; Kahraman, A.; Gerken, G.; Canbay, A. Obesity affects the liver-The link between adipocytes and hepatocytes. Digestion 2011, 83, 124-133.
22. Lottenberg, A.M.; Afonso Mda. S.; Lavrador, M.S.; Machado, R.M.; Nakandakare, E.R. The role of dietary fatty acids in the pathology of metabolic syndrome. J. Nutr. Biochem. 2012, 23, 1027-1040.
23. Bäckhed, F.; Ding, H.; Wang, T.; Hooper, L.V.; Koh, G.Y.; Nagy, A.; Semenkovich, C.F.; Gordon, J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 2004, 101, 15718-15723.
24. Rivera, C.A.; Adegboyega, P.; van Rooijen, N.; Tagalicud, A.; Allman, M.; Wallace, M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J. Hepatol. 2007, 47, 571-579.
25. Miura, K.; Kodama, Y.; Inokuchi, S.; Schnabl, B.; Aoyama, T.; Ohnishi, H.; Olefsky, J.M.; Brenner, D.A.; Seki, E. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology 2010, 139, 323-334.
26. Henao-Mejia, J.; Elinav, E.; Jin, C.; Hao, L.; Mehal, W.Z.; Strowig, T.; Thaiss, C.A.; Kau, A.L.; Eisenbarth, S.C.; Jurczak, M.J.; et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482, 179-185.
27. Miele, L.; Marrone, G.; Lauritano, C.; Cefalo, C.; Gasbarrini, A.; Day, C.; Grieco, A. Gut-liver axis and microbiota in NAFLD: Insight pathophysiology for novel therapeutic target. Curr. Pharm. Des. 2013, 19, 5314-5324.
28. Mehta, N.N.; McGillicuddy, F.C.; Anderson, P.D.; Hinkle, C.C.; Shah, R.; Pruscino, L.; Tabita-Martinez, J.; Sellers, K.F.; Rickels, M.R.; Reilly, M.P. Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 2010, 59, 172-181.
29. Csak, T.; Ganz, M.; Pespisa, J.; Kodys, K.; Dolganiuc, A.; Szabo, G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 2011, 54, 133-144.
30. Ruiz, A.G.; Casafont, F.; Crespo, J, Cayón, A.; Mayorga, M.; Estebanez, A.; Fernadez-Escalante, J.C.; Pons-Romero, F. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: Evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes. Surg. 2007, 17, 1374-1380.
31. Ottman, N.; Smidt, H.; de Vos, W.M.; Belzer, C. The function of our microbiota: Who is out there and what do they do? Front. Cell Infect. Microbiol. 2012, 2, 104.
32. Visschers, R.G.; Luyer, M.D.; Schaap, F.G.; Olde Damink, S.W.; Soeters, P.B. The gut-liver axis. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16, 576-581.
33. Craciun, S.; Balskus, E.P. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc. Natl. Acad. Sci. USA 2012, 109, 21307-21312.
34. Farrell, G.C.; van Rooyen, D.; Gan, L.; Chitturi, S. NASH is an inflammatory disorder: Pathogenic, prognostic and therapeutic implications. Gut Liver 2012, 6, 149-171.
35. Turnbaugh, P.J.; Ley, R.E.; Mahowald, M.A.; Magrini, V.; Mardis, E.R.; Gordon, J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444, 1027-1031.
36. Machado, M.V.; Cortez-Pinto, H. Gut microbiota and nonalcoholic fatty liver disease. Ann. Hepatol. 2012, 11, 440-449.
37. Moschen, A.R.; Kaser, S.; Tilg, H. Non-alcoholic steatohepatitis: A microbiota-driven disease. Trends Endocrinol. Metab. 2013, 24, 537-545.
38. Aron-Wisnewsky, J.; Gaborit, B.; Dutour, A.; Clement, K. Gut microbiota and non-alcoholic fatty liver disease: New insights. Clin. Microbiol. Infect. 2013, 19, 338-348.
39. Vajro, P.; Paolella, G.; Poeta, M.; Pizza, C.; Sangermano, M.; Massa, G. Pediatric non alcoholic fatty liver disease: More on novel treatment targets. BMC Pediatr. 2013, 13, 109.
40. Alisi, A.; Ceccarelli, S.; Panera, N.; Nobili, V. Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis. Front. Cell. Infect. Microbiol. 2012, 2, 132.
41. Li, D.Y.; Yang, M.; Edwards, S.; Ye, S.Q. Nonalcoholic fatty liver disease: For better or worse, blame the gut microbiota? J. Parenter. Enteral. Nutr. 2013, 37, 787-793.
42. Dubourg, G.; Lagier, J.C.; Armougom, F.; Robert, C.; Hamad, I.; Brouqui, P.; Raoult, D. The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics. Eur. J. Clin. Microbiol. Infect. Dis. 2013, 32, 637-645.
43. Del Chierico, F.; Vernocchi, P.; Bonizzi, L.; Carsetti, R.; Castellazzi, A.M.; Dallapiccola, B.; de Vos, W.; Guerzoni, M.E.; Manco, M.; Marseglia, G.L.; et al. Early-life gut microbiota under physiological and pathological conditions: The central role of combined meta-omics-based approaches. J. Proteomics 2012, 75, 4580-4587.
44. Lagier, J.C.; Million, M.; Hugon, P.; Armougom, F.; Raoult, D. Human gut microbiota: Repertoire and variations. Front Cell Infect Microbiol. 2012, 2, 136.
45. Lagier, J.C.; Armougom, F.; Million, M.; Hugon, P.; Pagnier, I.; Robert, C.; Bittar, F.; Fournous, G.; Gimenez, G.; Maraninchi, M.; et al. Microbial culturomics: Paradigm shift in the human gut microbiome study. Clin. Microbiol. Infect. 2012, 18, 1185-1193.
46. Satokari, R.M.; Vaughan, E.E.; Smidt, H.; Saarela, M.; Mättö, J.; de Vos, W.M. Molecular approaches for the detection and identification of bifidobacteria and lactobacilli in the human gastrointestinal tract. Syst. Appl. Microbiol. 2003, 26, 572-584.
47. Rajilić-Stojanović, M.; Heilig, H.G.; Molenaar, D.; Kajander, K.; Surakka, A.; Smidt, H.; de Vos, W.M. Development and application of the human intestinal tract chip, a phylogenetic microarray: Analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ. Microbiol. 2009, 11, 1736-1751.
48. Satokari, R.M.; Vaughan, E.E.; Akkermans, A.D.; Saarela, M.; de Vos, W.M. Polymerase chain reaction and denaturing gradient gel electrophoresis monitoring of fecal bifidobacterium populations in a prebiotic and probiotic feeding trial. Syst. Appl. Microbiol. 2001, 24, 227-231.
49. Claesson, M.J.; Wang, Q.; O'Sullivan, O.; Greene-Diniz, R.; Cole, J.R.; Ross, R.P.; O'Toole, P.W. Comparison of two next-generation sequencing technologies for resolving highly complex microbiota composition using tandem variable 16S rRNA gene regions. Nucleic Acids Res. 2010, 38, e200.
50. Salonen, A.; Nikkilä, J.; Jalanka-Tuovinen, J.; Immonen, O.; Rajilić-Stojanović, M.; Kekkonen, R.A.; Palva, A.; de Vos, W.M. Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: Effective recovery of bacterial and archaeal DNA using mechanical cell lysis. J. Microbiol. Methods 2010, 81, 127-134.
51. Petrucca, A.; del Chierico, F.; Putignani, L. Just keep going on description or interpret "life" of gut microbial ecosystems? Available online: http://www.cell.com/abstract/S0092-8674(12)00629-0#(accessed on 23 October 2012); Comments.
52. Arumugam, M.; Raes, J.; Pelletier, E.; Le Paslier, D.; Yamada, T.; Mende, D.R.; Fernandes, G.R.; Tap, J.; Bruls, T.; Batto, J.M. Enterotypes of the human gut microbiome. Nature 2011, 473, 174-180.
53. Eckburg, P.B.; Bik, E.M.; Bernstein, C.N.; Purdom, E.; Dethlefsen, L.; Sargent, M.; Gill, S.R.; Nelson, K.E.; Relman, D.A. Diversity of the human intestinal microbial flora. Science 2005, 308, 1635-1638.
54. Martins dos Santos, V.; Müller, M.; de Vos, W.M. Systems biology of the gut: The interplay of food, microbiota and host at the mucosal interface. Curr. Opin. Biotechnol. 2010, 21, 539-550.
55. Salonen, A.; de Vos, WM.; Palva, A. Gastrointestinal microbiota in irritable bowel syndrome: Present state and perspectives. Microbiology 2010, 156, 3205-3215.
56. Zoetendal, E.G.; Rajilic-Stojanovic, M.; de Vos, W.M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008, 57, 1605-1615.
57. Booijink, C.C.; Zoetendal, E.G.; Kleerebezem, M.; de Vos, W.M. Microbial communities in the human small intestine: Coupling diversity to metagenomics. Future Microbiol. 2007, 2, 285-295.
58. Palmer, C.; Bik, E.M.; DiGiulio, D.B.; Relman, D.A.; Brown, P.O. Development of the human infant intestinal microbiota. PLoS Biol. 2007, 5, e177.
59. Wang, H.X.; Geng, Z.L.; Zeng, Y.; Shen, Y.M. Enriching plant microbiota for a metagenomic library construction. Environ. Microbiol. 2008, 10, 2684-2691.
60. Chadeau-Hyam, M.; Ebbels, T.M.; Brown, I.J.; Chan, Q.; Stamler, J.; Huang, C.C.; Daviglus, M.L.; Ueshima, H.; Zhao, L.; Holmes, E.; et al. Metabolic profiling and the metabolome-wide association study: Significance level for biomarker identification. J. Proteome Res. 2010, 9, 4620-4627.
61. Martin, F.P.; Sprenger, N.; Montoliu, I.; Rezzi, S.; Kochhar, S.; Nicholson, J.K. Dietary modulation of gut functional ecology studied by fecal metabonomics. J. Proteome Res. 2010, 9, 5284-5295.
62. Vitali, B.; Ndagijimana, M.; Cruciani, F.; Carnevali, P.; Candela, M.; Guerzoni, M.E.; Brigidi, P. Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol. 2010, 10, 4.
63. Saric, J.; Wang, Y.; Li, J.; Coen, M.; Utzinger, J.; Marchesi, J.R.; Keiser, J.; Veselkov, K.; Lindon, J.C.; Nicholson, J.K.; et al. Species variation in the fecal metabolome gives insight into differential gastrointestinal function. J. Proteome Res. 2008, 7, 352-360.
64. Nicholson, J.K.; Lindon, J.C.; Holmes, E. "Metabonomics": Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29, 1181-1189.
65. Li, H.; Xie, Z.; Lin, J.; Song, H.; Wang, Q.; Wang, K.; Su, M.; Qiu, Y.; Zhao, T.; Song, K.; et al. Transcriptomic and metabonomic profiling of obesity-prone and obesity-resistant rats under high fat diet. J. Proteome Res. 2008, 7, 4775-4783.
66. Nicholson, J.K.; Holmes, E.; Wilson, I.D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 2005, 3, 431-438.
67. Young, S.P.; Wallace, G.R. Metabolomic analysis of human disease and its application to the eye. J. Ocul. Biol. Dis. Infor. 2009, 2, 235-242.
68. Del Chierico, F.; Petrucca, A.; Mortera, S.L.; Vernocchi, P.; Rosado, M.M.; Pieroni, L.; Carsetti, R.; Urbani, A.; Putignani, L. A metaproteomic pipeline to identify newborn mouse gut phylotypes. J. Proteomics 2013, in press.
69. Caporaso, J.G.; Kuczynski, J.; Stombaugh, J.; Bittinger, K.; Bushman, F.D.; Costello, E.K.; Fierer, N.; Peña, A.G.; Goodrich, J.K.; Gordon, J.I.; et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7, 335-336.
70. Reeder, J.; Knight, R. Rapidly denoising pyrosequencing amplicon reads by exploiting rank-abundance distributions. Nat. Methods 2010, 7, 668-669.
71. Edgar, R.C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010, 26, 2460-2461.
72. Wang, Q.; Garrity, G.M.; Tiedje, J.M.; Cole, J.R. Naïve Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 2007, 73, 5261-5267.
73. McDonald, D.; Price, M.N.; Goodrich, J.; Nawrocki, E.P.; DeSantis, T.Z.; Probst, A.; Andersen, G.L.; Knight, R.; Hugenholtz, P. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012, 6, 610-618.
74. Chao, A.; Bunge, J. Estimating the number of species in a stochastic abundance model. Biometrics 2002, 58, 531-539.
75. Shannon, C.E.; Weaver, W. The mathematical theory of information. AT&T Tech. J. 1949, 27, 359-423.
76. Lozupone, C.; Lladser, M.E.; Knights, D.; Stombaugh, J.; Knight, R. UniFrac: An effective distance metric for microbial community comparison. ISME J. 2011, 5, 169-172.
77. Kohl, M.; Wiese, S.; Warscheid, B. Cytoscape: Software for visualization and analysis of biological networks. Methods Mol. Biol. 2011, 696, 291-303.
78. Penders, J.; Thijs, C.; Vink, C.; Stelma, F.F.; Snijders, B.; Kummeling, I.; van den Brandt, P.A.; Stobberingh, E.E. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118, 511-521.
79. Koenig, J.E.; Spor, A.; Scalfone, N.; Fricker, A.D.; Stombaugh, J.; Knight, R.; Angenent, L.T.; Ley, R.E. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl. Acad. Sci. USA 2011, 15, 4578-4585.
80. Jost, T.; Lacroix, C.; Braegger, C.P.; Chassard, C. New insights in gut microbiota establishment in healthy breast fed neonates. PLoS One 2012, 7, e44595.
81. Coppa, G.V.; Zampini, L.; Galeazzi, T.; Gabrielli, O. Prebiotics in human milk: A review. Dig. Liver Dis. 2006, 38, 291-294.
82. Zivkovic, A.M.; Barile, D. Bovine milk as a source of functional oligosaccharides for improving human health. Adv. Nutr. 2011, 2, 284-289.
83. White, R.A.; Bjørnholt, J.V.; Baird, D.D., Midtvedt, T.; Harris, J.R.; Pagano, M.; Hide, W.; Rudi, K.; Moen, B.; Iszatt, N.; et al. Novel developmental analyses identify longitudinal patterns of early gut microbiota that affect infant growth. PLoS Comput. Biol. 2013, 9, e1003042.
84. Zhang, C.; Zhang, M.; Wang, S.; Han, R.; Cao, Y.; Hua, W.; Mao, Y.; Zhang, X.; Pang, X.; Wie, C.; et al. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 2010, 4, 232-241.
85. Sekirov, I.; Russell, S.; Caetano, L.; Antunes, M.; Finlay, B.B. Gut microbiota in health and disease. Am. Physiol. Soc. 2010, 90, 859-904.
86. Turnbaugh, P.J.; Ridaura, V.K.; Faith, J.J.; Rey, F.E.; Knight, R.; Gordon, J.I. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009, 1, 6ra14.
87. Walker, A.W.; Ince, J.; Duncan, S.H.; Webster, L.M.; Holtrop, G.; Ze, X.; Brown, D.; Stares, M.D.; Scott, P.; Bergerat, A.; et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011, 5, 220-230.
88. Santacruz, A.; Marcos, A.; Warnberg, J.; Marti, A.; Martin-Matillas, M.; Campoy, C.; Moreno, L.A.; Veiga, O.; Redondo-Figuero, C.; Garagorri, J.M.; et al. Interplay between weight loss and gut microbiota composition in overweight adolescents. Obesity 2009, 17, 1906-1915.
89. Pokusaeva, K.; Fitzgerald, G.F.; van Sinderen, D. Carbohydrate metabolism in bifidobacteria. Genes Nutr. 2011, 6, 285-306.
90. Begley, M.; Hill, C.; Gahan, C.G. Bile salt hydrolase activity in probiotics. Appl. Environ. Microbiol. 2006, 72, 1729-1738.
91. Zimmer, J.; Lange, B.; Frick, J.S.; Sauer, H.; Zimmermann, K.; Schwiertz, A.; Rusch, K.; Klosterhalfen, S.; Enck, P. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur. J. Clin. Nutr. 2012, 66, 53-60.
92. De Filippo, C.; Cavalieri, D.; di Paola, M.; Ramazzotti, M.; Poullet, J.B.; Massart, S.; Collini, S.; Pieraccini, G.; Lionetti, P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from europe and rural africa. Proc. Natl. Acad. Sci. USA 2010, 107, 14691-14696.
93. Hehemann, J.H.; Correc, G.; Barbeyron, T.; Helbert, W.; Czjzek, M.; Michel, G. Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010, 8, 908-912.
94. Abu-Shanab, A.; Quigley, E.M. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 2010, 7, 691-701.
95. Frasinariu, O.E.; Ceccarelli, S.; Alisi, A.; Moraru, E.; Nobili, V. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies. Digest. Liver Dis. 2013, 45, 543-551.
96. Cani, P.D.; Amar, J.; Iglesias, M.A.; Poggi, M.; Knauf, C.; Bastelica, D.; Neyrinck, A.M.; Fava, F.; Tuohy, K.M.; Chabo, C.; et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56, 1761-1772.
97. Turnbaugh, P.J.; Gordon, J.I. The core gut microbiome, energy balance and obesity. J. Physiol. 2009, 587, 4153-4158.
98. Spencer, M.D.; Hamp, T.J.; Reid, R.W.; Fischer, L.M.; Zeisel, S.H.; Fodor, A.A. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 2011, 140, 976-986.
99. Le Roy, T.; Llopis, M.; Lepage, P.; Bruneau, A.; Rabot, S.; Bevilacqua, C.; Martin, P.; Philippe, C.; Walker, F.; Bado, A.; et al. Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 2013, 62, 1787-1794.
100. Mouzaki, M.; Comelli, E.M.; Arendt, B.M.; Bonengel, J.; Fung, S.K.; Fischer, S.E.; McGilvray, I.D.; Allard, J.P. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 2013, 58, 120-127.
101. Ley, R.E.; Turnbaugh, P.J.; Klein, S.; Gordon, J.I. Microbial ecology: Human gut microbes associated with obesity. Nature 2006, 444, 1022-1023.
102. Bull-Otterson, L.; Feng, W.; Kirpich, I.; Wang, Y.; Qin, X.; Liu, Y.; Gobejishvili, L.; Joshi-Barve, S.; Ayvaz, T.; Petrosino, J.; et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One 2013, 8, e53028.
103. Yin, X.; Peng, J.; Zhao, L.; Yu, Y.; Zhang, X.; Liu, P.; Feng, Q.; Hu, Y.; Pang, X. Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula. Syst. Appl. Microbiol. 2013, 36, 188-196.
104. De Minicis, S.; Rychlicki, C.; Agostinelli, L.; Saccomanno, S.; Candelaresi, C.; Trozzi, L.; Mingarelli, E.; Facinelli, B.; Magi, G.; Palmieri, C.; et al. Dysbiosis contributes to fibrogenesis in the course of chronic liver injury. Hepatology 2013, doi:10.1002/hep.26695.
105. Pachikian, B.D.; Essaghir, A.; Demoulin, J.B.; Catry, E.; Neyrinck, A.M.; Dewulf, E.M.; Sohet, F.M.; Portois, L.; Clerbaux, L.A.; Carpentier, Y.A.; et al. Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways. Mol. Nutr. Food Res. 2013, 57, 347-359.
106. Raman, M.; Ahmed, I.; Gillevet, P.M.; Probert, C.S.; Ratcliffe, N.M.; Smith, S.; Greenwood, R.; Sikaroodi, M.; Lam, V.; Crotty, P.; et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 2013, 11, 868-875.
107. Wong, V.W.; Tse, C.H.; Lam, T.T.; Wong, G.L.; Chim, A.M.; Chu, W.C.; Yeung, D.K.; Law, P.T.; Kwan, H.S.; Yu, J.; et al. Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis-A longitudinal study. PLoS One 2013, 8, e62885.
108. Zhu, L.; Baker, S.S.; Gill, C.; Liu, W.; Alkhouri, R.; Baker, R.D.; Gill, S.R. Characterization of gut microbiomes in nonalcoholic steatohepatitis(NASH) patients: A connection between endogenous alcohol and NASH. Hepatology 2013, 57, 601-609.
109. Sawada, K.; Ohtake, T.; Hasebe, T.; Abe, M.; Tanaka, H.; Ikuta, K.; Suzuki, Y.; Fujiya, M.; Hasebe, C.; Kohgo, Y. Augmented hepatic Toll-like receptors by fatty acids trigger the pro-inflammatory state of non-alcoholic fatty liver disease in mice. Hepatol. Res. 2013, doi:10.1111/hepr.12199.
110. Brunt, E.M. Pathology of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. 2010, 7, 195-203.
111. Jumpertz, R.; Le, D.S.; Turnbaugh, P.J.; Trinidad, C.; Bogardus, C.; Gordon, J.I.; Krakoff, J. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am. J. Clin. Nutr. 2011, 94, 58-65.
112. Compare, D.; Coccoli, P.; Rocco, A.; Tardone, O.M.; de Maria, S.; Cartenì, M.; Tardone, G. Gut-liver axis: The impact of gut microbiota on non alcoholic fatty liver disease. Nutr. Metab. Cardiovas. 2012, 22, 471-476.
113. Le Chatelier, E.; Nielsen, T.; Qin, J.; Prifti, E.; Hildebrand, F.; Falony, G.; Almeida, M.; Arumugam, M.; Batto, J.M.; Kennedy, S.; et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013, 500, 541-546.
114. Blomstrand, R. Observations of the formation of ethanol in the intestinal tract in man. Life Sci. II 1971, 10, 575-582.
115. Engeland, K.; Maret, W. Extrahepatic, differential expression of four classes of human alcohol dehydrogenase. Biochem. Biophys. Res. Commun. 1993, 193, 47-53.
116. Turnbaugh, P.J.; Hamady, M.; Yatsunenko, T.; Cantarel, B.L.; Duncan, A.; Ley, R.E.; Sogin, M.L.; Jones, W.J.; Roe, B.A.; Affourtit, J.P.; et al. A core gut microbiome in obese and lean twins. Nature 2009, 457, 480-484.
117. Jacobs, D.M.; Gaudier, E.; van Duynhoven, J.; Vaughan, E.E. Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: A role for metabolomics. Curr. Drug Metab. 2009, 10, 41-54.
118. Delzenne, N.M.; Neyrinck, A.M.; Cani, P.D. Gut microbiota and metabolic disorders: How prebiotic can work? Br. J. Nutr. 2013, 109, 81-85.
119. Wong, V.W.; Won, G.L.; Chim, A.M.; Chu, W.C.; Yeung, D.K.; Li, K.C.; Chan, H.L. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann. Hepatol. 2013, 12, 256-262.
120. Abenavoli, L.; Scarpellini, E.; Rouabhia, S.; Balsano, C.; Luzza, F. Probiotics in non-alcoholic fatty liver disease: Which and when. Ann. Hepatol. 2013, 12, 357-363.
121. Vajro, P.; Mandato, C.; Veropalumbo, C.; de Micco, I. Probiotics: A possible role in treatment of adult and pediatric non alcoholic fatty liver disease. Ann. Hepatol. 2013, 12, 161-163.
122. Kelishadi, R.; Farajian, S.; Mirlohi, M. Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidences. Hepat. Mon. 2013, 13, e7233.
123. De Filippo, C.; Ramazzotti, M.; Fontana, P.; Cavalieri, D. Bioinformatic approaches for functional annotation and pathway inference in metagenomics data. Brief Bioinform. 2012, 13, 696-710.
124. Shoaie, S.; Karlsson, F.; Mardinoglu, A.; Nookaew, I.; Bordel, S.; Nielsen, J. Understanding the interactions between bacteria in the human gut through metabolic modeling. Sci. Rep. 2013, 3, 2532.